Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: most interesting regarding disclosure statement
8
Jan 08, 2015 09:29PM
Interesing that TPL is stating that revenues to increase dramitically due to MMP...
Read Below
TPL’s revenues have stagnated since the filing of the Chapter 11 Petition and were on a
downward projector since 2010
,$10.1million in 2012, $11.3 mi
llion in 2011 and $17.6 million
in 2010); however, TPL believes that
the emergence from
bankruptcy, new management and the
additions of a second licensing agent for MMP Portfolio will be
the impetus for revenues to
increase significantly, and return to pre
-2009 levels as several
of the litigations reach pivotal points.....
12
Jan 08, 2015 11:39PM
5
Jan 09, 2015 12:50AM
Share
New Message
Please login to post a reply